Optimal Dosing of High-Intensity Locomotor Training for Step Attainment and Locomotor Outcomes in Stroke Patients Undergoing Acute Inpatient Rehabilitation
Starting soon · Not applicable
Conditions studied: Stroke
In brief
The purpose of this study is to elucidate optimal dosing for High Intensity Gait Training (HIGT) to reduce locomotor disability for those undergoing inpatient rehabilitation (IR) in the subacute phase of stroke recovery. This is a randomized controlled trial conducted at a single IR facility. Investigators will randomize patients to receive one of two distinct HIGT interventions or a high step count intervention during standard care.
Key facts
- Study ID
- NCT06637839
- Run by
- NYU Langone Health
- People needed
- 20
- Starts
- 2027-01-01
- Expected to finish
- 2027-12-01
- Last updated by the study team
- 2026-06-26
Who can join
Age: 18 and older, up to 95. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Primary diagnosis of stroke
You may not qualify if…
- Weightbearing restrictions, uncontrolled cardiopulmonary, metabolic, infectious, or psychiatric disorders, which would preclude aerobic locomotor training
- Estimated length of stay of less than 14 days
- Non-ambulatory status prior to admission (unable to walk >50 meters)
- Pregnant
Where it is running
- NYU Langone Health — New York, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.